Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994 Oct;39(4):217-22.
doi: 10.1007/BF01525984.

Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer

P Purasiri  1 , J Ashby, S D Heys, O Eremin
Affiliations
Clinical Trial

Effect of essential fatty acids on circulating T cell subsets in patients with colorectal cancer

P Purasiri et al. Cancer Immunol Immunother. 1994 Oct.

Abstract

The effect of essential fatty acids (EFA), given orally as dietary supplements, on the responsiveness in vitro of peripheral blood lymphocytes (PBL), to the mitogen concanavalin A have been studied in 10 patients with localized and 14 patients with advanced colorectal cancer. The degree of lymphocyte activation was assessed by measuring the amount of tritiated [3H]thymidine incorporated into newly synthesised lymphocyte DNA. The results were expressed as stimulation indices. T cell responses to concanavalin A stimulation showed a significant reduction of stimulation indices following EFA supplementation, in both the localized (P = 0.026) and advanced (P = 0.016) tumour groups, when compared with pretreatment activity in vitro. Mixing experiments, using EFA-supplemented and non-EFA-supplemented lymphocytes with concanavalin A, suggest no enhancement of T suppressor cell activity. Cell surface marker analysis (fluorescence-activated cell sorting for CD phenotyping) revealed a reduction of absolute numbers of CD4+ and CD8+ lymphocytes following EFA supplementation. The stimulation indices returned to pre-supplementation values 3 months following cessation of EFA intake. There was no significant change of these indices in the control (no EFA supplementation) advanced tumour group tested. This study suggests that EFA supplementation in patients with colorectal cancer selectively reduces circulating PBL, and T cell subset (including suppressor cells) numbers and/or activity. Such effects may have an important outcome in patients with malignant disease.

PubMed Disclaimer

References

    1. Anel A, Naval J, Gonzalez B, Uriel J, Pineiro A. Fatty acid metabolism in human lymphocytes. II. Activation of fatty acid desaturase-elongese system during blastic transformation. Biochim Biophys Acta. 1990;1044:332–339. - PubMed
    1. Begin ME, Ells G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented withn-3 andn-6 polyunsaturated fatty acids. J Natl Cancer Inst. 1986;77:1053–1062. - PubMed
    1. Brooks B, Arch RS, Newsholme EA. Effects of hormones on the rate of the triacylglycerol/fatty acid substrate cycle in adipocytes and epididymal fat pads. FEBS Lett. 1982;146:327–330. - PubMed
    1. Bittiner SB, Tucker WFG, Cartwright I, Bleehen SS. A double blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet. 1988;I:378–380. - PubMed
    1. Boyum AI. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968;97(Suppl 21):77–89. - PubMed

Publication types